Benoit Hennion

"Frédéric Bodin, Professor of Plastic Surgery, was taking over 200 photos a week and had no tools to sort and store them safely. In 2018, he went to a health innovation competition with the idea of creating an app to manage his medical photos. It was there that he met entrepreneur Matis Ringdal and engineer Vincent Marceddu. The prototype app they developed won several awards. "It all came together in 2019 when they founded the company and signed their first hospital contracts. Pixacare won the i-Lab contest, a government program that supports innovative startups. Concurrently, the company announced its first financing round of 2 million euros. In early 2023, the medical imaging library and wound management solutions received their CE marking for medical devices. Meanwhile, engineers have been developing AI technologies to measure and analyse chronic wounds. In 2023, Pixacare has been implemented in 20 hospitals across France and internationally. The application has registered over 50,000 patients and 250,000 photos. At the companys headquarters, the team now consists of 20 employees.

Diagnostics for Better care, Everywhere. En Carta Diagnostics is a synthetic-biology biotech company leveraging patented technologies to decentralise highly reliable molecular diagnostic solutions.

Surge develops PreCyte, an immune-based diagnostic approach to identify patients at risk of postoperative complications and support smarter discharge and care pathways. PreCyte focuses on immune signatures associated with surgical site infection and pulmonary complications, helping care teams intervene earlier and allocate resources more effectively. Use cases - Postoperative risk stratification for surgical site infection and pulmonary complications - Support for discharge timing and pathway optimization in perioperative care - Immune profiling to inform patient monitoring and follow-up decisions Proof points - Early clinical deployments with leading academic medical centers - Built on more than a decade of translational immunology and multi-omics research - Developed with a strong focus on quality, clinical proofpoints, and technological breakthroughs

At Norbert, we make vital signs scanning and monitoring fast, efficient, easy and ubiquitous. We have built the first ever ambient health scanner that can measure vital signs for anyone within a 6 ft range and does not require any effort from the person being scanned. Heart rate, pleth plot, breathing rate, temperature, Pulse Wave Velocity and more. Norbert is currently accepting applications for our Healthcare Pilot Program. If you’re interested in learning more about our healthcare solutions and how we can support your hospital, clinic or other care center, contact us below.

"Frédéric Bodin, Professor of Plastic Surgery, was taking over 200 photos a week and had no tools to sort and store them safely. In 2018, he went to a health innovation competition with the idea of creating an app to manage his medical photos. It was there that he met entrepreneur Matis Ringdal and engineer Vincent Marceddu. The prototype app they developed won several awards. "It all came together in 2019 when they founded the company and signed their first hospital contracts. Pixacare won the i-Lab contest, a government program that supports innovative startups. Concurrently, the company announced its first financing round of 2 million euros. In early 2023, the medical imaging library and wound management solutions received their CE marking for medical devices. Meanwhile, engineers have been developing AI technologies to measure and analyse chronic wounds. In 2023, Pixacare has been implemented in 20 hospitals across France and internationally. The application has registered over 50,000 patients and 250,000 photos. At the companys headquarters, the team now consists of 20 employees.

Diagnostics for Better care, Everywhere. En Carta Diagnostics is a synthetic-biology biotech company leveraging patented technologies to decentralise highly reliable molecular diagnostic solutions.

Tamrisa is a specialized pharma venture dedicated to tackling Anti-Microbial Resistance (AMR) through Innovation, Stewardship and Access. Tamrisa aims to provide a novel, comprehensive, ambitious and sustainable response to AMR threat, in line with the guidelines set by WHO.

Surge develops PreCyte, an immune-based diagnostic approach to identify patients at risk of postoperative complications and support smarter discharge and care pathways. PreCyte focuses on immune signatures associated with surgical site infection and pulmonary complications, helping care teams intervene earlier and allocate resources more effectively. Use cases - Postoperative risk stratification for surgical site infection and pulmonary complications - Support for discharge timing and pathway optimization in perioperative care - Immune profiling to inform patient monitoring and follow-up decisions Proof points - Early clinical deployments with leading academic medical centers - Built on more than a decade of translational immunology and multi-omics research - Developed with a strong focus on quality, clinical proofpoints, and technological breakthroughs

At Norbert, we make vital signs scanning and monitoring fast, efficient, easy and ubiquitous. We have built the first ever ambient health scanner that can measure vital signs for anyone within a 6 ft range and does not require any effort from the person being scanned. Heart rate, pleth plot, breathing rate, temperature, Pulse Wave Velocity and more. Norbert is currently accepting applications for our Healthcare Pilot Program. If you’re interested in learning more about our healthcare solutions and how we can support your hospital, clinic or other care center, contact us below.